Close

Featured

Novartis Announces $250M Funding In R&D For NTDs, Malaria

Novartis has committed to investing $250 million in research and development over the next five years in an effort to find a cure for malaria and other neglected tropical diseases (NTDs). CEO Vas Narasimhan remarked in a statement that...

GSK Pledges £1 Billion R&D Commitment For The Poor Nations

In order to speed up research and development (R&D) for communicable diseases that disproportionately hurt lower-income nations, GSK plc announced a commitment of £1 billion over 10 years. This research will focus on novel and ground-breaking vaccines and medications to diagnose...

Selecting an optimized stability plan for your injectable drug product

No matter the indication, molecule, or therapeutic area, every drug developer working on a parenteral medication needs to answer the same essential question: what’s the best approach to retaining the product’s stability? The answer is critically important from your very...

Keeping The Risk of Packaging In Check With Kids Involved

In the pharmaceutical industry and other consumer markets that produce and sell hazardous substances, child-resistant packaging has become an essential element of packaging design. As legislation and regulations increase all around the world and more firms take the moral pledge...

4 Trends Transforming the Never-Normal Future of Manufacturing

2021 Manufacturing Trends If 2020 was the year of disruption, 2021 is the year of adaptation. Download this trend brief to explore ways that manufacturers are adapting to change and evolving to stay competitive. What's Included: Embracing digitization. Liberating data. Balancing...

Vaccine Temperatures: Keeping it cool for COVID-19

With more vaccines being approved worldwide, maintaining the shipments’ integrity throughout the delivery process is the most challenging hurdle for many logistics providers. Since the first COVID-19 vaccine was approved in December last year – Pfizer-BioNTech’s mRNA vaccine – there...

Redefining interoperability in the digital age

From Amazon pharmacy to Apple Health to Epic and Cerner battles to digital drug companions, the state of healthcare interoperability has come alive with digital power. And the COVID-19 pandemic accelerated this ability making telehealth mainstream for most medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read